These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8976686)

  • 21. Effect of exogenous surfactant on the development of surfactant synthesis in premature rabbit lung.
    Amato M; Petit K; Fiore HH; Doyle CA; Frantz ID; Nielsen HC
    Pediatr Res; 2003 Apr; 53(4):671-8. PubMed ID: 12612208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyaluronan decreases surfactant inactivation in vitro.
    Lu KW; Goerke J; Clements JA; Taeusch HW
    Pediatr Res; 2005 Feb; 57(2):237-41. PubMed ID: 15585679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surface activity of lipid extract surfactant in relation to film area compression and collapse.
    Schürch S; Schürch D; Curstedt T; Robertson B
    J Appl Physiol (1985); 1994 Aug; 77(2):974-86. PubMed ID: 8002555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Properties of modified natural surfactant after exposure to fibrinogen in vitro and in an animal model of respiratory distress syndrome.
    Calkovska A; Linderholm B; Haegerstrand-Björkman M; Curstedt T
    Pediatr Res; 2012 Sep; 72(3):262-9. PubMed ID: 22691953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Natural and synthetic surfactant in the treatment of neonatal respiratory distress syndrome].
    Bratlid D; Farstad T
    Tidsskr Nor Laegeforen; 1994 Jan; 114(1):33-6. PubMed ID: 8296279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structures of pulmonary surfactant films adsorbed to an air-liquid interface in vitro.
    Bachofen H; Gerber U; Gehr P; Amrein M; Schürch S
    Biochim Biophys Acta; 2005 Dec; 1720(1-2):59-72. PubMed ID: 16405864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations.
    Seeger W; Grube C; Günther A; Schmidt R
    Eur Respir J; 1993 Jul; 6(7):971-7. PubMed ID: 8370446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surface properties of rat pulmonary surfactant studied with the captive bubble method: adsorption, hysteresis, stability.
    Schürch S; Bachofen H; Goerke J; Green F
    Biochim Biophys Acta; 1992 Jan; 1103(1):127-36. PubMed ID: 1730014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bulk shear viscosities of endogenous and exogenous lung surfactants.
    King DM; Wang Z; Palmer HJ; Holm BA; Notter RH
    Am J Physiol Lung Cell Mol Physiol; 2002 Feb; 282(2):L277-84. PubMed ID: 11792632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
    Long W; Corbet A; Cotton R; Courtney S; McGuiness G; Walter D; Watts J; Smyth J; Bard H; Chernick V
    N Engl J Med; 1991 Dec; 325(24):1696-703. PubMed ID: 1944470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of liposomal and polycationic transfection complexes with pulmonary surfactant.
    Ernst N; Ulrichskötter S; Schmalix WA; Rädler J; Galneder R; Mayer E; Gersting S; Plank C; Reinhardt D; Rosenecker J
    J Gene Med; 1999; 1(5):331-40. PubMed ID: 10738550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of budesonide and salbutamol on surfactant properties.
    Palmer D; Schürch S; Belik J
    J Appl Physiol (1985); 2000 Sep; 89(3):884-90. PubMed ID: 10956330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surfactant therapy and high-frequency jet ventilation in the management of a piglet model of the meconium aspiration syndrome.
    Wiswell TE; Peabody SS; Davis JM; Slayter MV; Bent RC; Merritt TA
    Pediatr Res; 1994 Oct; 36(4):494-500. PubMed ID: 7816525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biophysical and chemical stability of surfactant/budesonide and the pulmonary distribution following intra-tracheal administration.
    Chen CM; Chang CH; Chao CH; Wang MH; Yeh TF
    Drug Deliv; 2019 Dec; 26(1):604-611. PubMed ID: 31204848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Commercial versus native surfactants. Surface activity, molecular components, and the effect of calcium.
    Bernhard W; Mottaghian J; Gebert A; Rau GA; von Der HARDT H; Poets CF
    Am J Respir Crit Care Med; 2000 Oct; 162(4 Pt 1):1524-33. PubMed ID: 11029372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The effect of surfactant therapy on the oxygen treatment of premature infants with HMD].
    Iarŭkova N
    Akush Ginekol (Sofiia); 1998; 37(1):3-5. PubMed ID: 9770786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of exosurf (surfactant)-mediated suppression of stimulated human alveolar macrophage cytokine responses.
    Thomassen MJ; Antal JM; Connors MJ; Meeker DP; Wiedemann HP
    Am J Respir Cell Mol Biol; 1994 Apr; 10(4):399-404. PubMed ID: 8136155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exogenous porcine surfactant (Curosurf) is inactivated by monoclonal antibody to the surfactant-associated hydrophobic protein SP-B.
    Kobayashi T; Robertson B; Grossmann G; Nitta K; Curstedt T; Suzuki Y
    Acta Paediatr; 1992 Sep; 81(9):665-71. PubMed ID: 1421904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Susceptibility of exogenous surfactant to phospholipase A2 degradation.
    Duncan JE; Hatch GM; Belik J
    Can J Physiol Pharmacol; 1996 Aug; 74(8):957-63. PubMed ID: 8960386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Surface-active properties of phosphatidylcholines--basis for surfactant replacement therapy].
    Zakharova TS; Fortinskaia ES; Kochetova MM; Babakhanov ISh; Torkhovskaia TI; Khalilov EM
    Biull Eksp Biol Med; 2000 Feb; 129(2):168-70. PubMed ID: 10732237
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.